Assessing sexual health needs in patients with advanced cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the sexual health needs and quality of life of patients diagnosed with advanced-stage cancer. It focuses on understanding the unmet sexual health needs of patients in palliative care, utilizing sexual satisfaction questionnaires for both patients and their life partners. The study seeks to gather insights that could inform the development of effective interventions to address these needs. By integrating sexual health into cancer care, the study aims to enhance the overall well-being of patients during their treatment journey.

Why it matters

Who can join: the full rules

Inclusion Criteria:

For patients:

* Individuals aged 18 and older,
* Patients diagnosed with advanced solid or hematological cancers,
* Whether or not undergoing specific treatment for the ongoing oncological condition,
* Having a cancer diagnosis for more than 3 months (baseline diagnosis consultation),
* Capable of understanding study-related documents,
* Capable of completing questionnaires,
* Fluent in French,
* Individuals who have not objected to participating in the study.

For partners:

* Individuals aged 18 and older,
* Individuals whose life partner has been diagnosed with advanced solid or hematological cancer for more than 3 months, whether or not they have received treatment,
* Capable of understanding study-related documents,
* Capable of completing questionnaires,
* Fluent in French,
* Individuals who have not objected to participating in the study.

Exclusion Criteria:

* Individuals unable to complete the entire questionnaire due to their clinical condition.
* Individuals under guardians, curators, or legal protection.

Where it's running

• Centre hospitalier de la Croix Rousse, Hospices Civils de Lyon
  Lyon, France Recruiting
• Centre Hospitalier Edouard Herriot, Hospices Civils de Lyon
  Lyon, France Recruiting
• Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
  Lyon, France Recruiting

Study contacts

• Study coordinator: Roxane MD DONZ
• Email: roxane.donz@chu-lyon.fr
• Phone: 4 78 86 41 48

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Concise coaching to guide decisions for advanced cancer patients considering palliative procedures

  A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.

  Recruiting Singapore General Hospital · Singapore · NCT07789093

• Primary Palliative Care: A Feasibility Project for Family Health Units

  This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.

  Recruiting University of Coimbra · Coimbra and 1 other locations · NCT07737899

• Virtual Group Resilient Living for Advanced Cancer

  A group-based online program tests whether seven weekly sessions can reduce anxiety and fatigue and improve quality of life for adults with advanced cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07659158

• IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy

  This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07648160

• Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain

  A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07636382

• UI-102 in advanced cancers (phase 1/2) first-in-human

  A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.

  Recruiting at 3 sites Phase 1/2 United Immunity, co., Ltd. · Dallas, Texas and 2 other locations · NCT07605962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.